Back to medications
Medication monograph
dabrafenib
BRAF Kinase InhibitorsAntineoplasticsKinase InhibitorChemotherapeutic Agents
Clinical reference
Product monograph
TAFINLAR- dabrafenib capsuleTAFINLAR- dabrafenib tablet, for suspension
Brands & formulations
Family members
TAFINLAR
Marketed10 MGORALTABLET FOR SUSPENSION[
"dabrafenib (dabrafenib mesylate)"
]
Product monograph Pricing
Price information
Tafinlar Capsule
Novartis · 50 mg
120: $9285.7
Tafinlar Capsule
Novartis · 75 mg
120: $13985.7
Classification
- Chemical class
- BRAF Kinase Inhibitors
- Clinical class
- Antineoplastics
- Banks class
- Kinase Inhibitor
- AHFS family
- Chemotherapeutic Agents